IPA Live-Signale | Maximieren Sie Profite mit Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 Apr 2024 @ 22:00):

ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally...

Stats
Tagesvolumen	51 626.00
Durchschnittsvolumen	606 177
Marktkapitalisierung	36.05M
EPS	$0 ( 2024-03-21 )
Nächstes Ertragsdatum	( $-0.100 ) 2024-07-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-2.91
ATR14	$0.0140 (1.02%)

Insider Trading

Date	Person	Action	Amount	type
2008-12-12	Aisling Capital Ii Lp	Buy	861 826	Convertible 12% Note Due 2009
2008-12-12	Aisling Capital Ii Lp	Buy	10 412	Series D-1 Convertible Preferred Stock
2008-12-12	Aisling Capital Ii Lp	Buy	1	Warrant (right to buy)
2008-12-12	Aisling Capital Ii Lp	Buy	1	Warrant (right to buy)
2008-12-12	Aisling Capital Ii Lp	Sell	10 000	Series C-1 Convertible Preferred Stock

INSIDER POWER
0.00
Last 20 transactions
Buy: 4 917 425 \| Sell: 9 058 105

Volumen Korrelation

Lang: -0.20 (neutral)

Kurz: 0.83 (strong)

Signal:(57.433) Same movement expected

ImmunoPrecise Antibodies Korrelation

10 Am meisten positiv korreliert
CBNK	0.964
ALRS	0.959
BWB	0.957
WTBA	0.956
UTHR	0.956
KNSA	0.955
HALO	0.952
SFST	0.951
AROW	0.951
WASH	0.95

10 Am meisten negativ korreliert
DUOL	-0.959
SVFAU	-0.957
LGACU	-0.957
APXI	-0.956
SVFA	-0.953
SCOB	-0.952
DSEY	-0.952
ALTR	-0.951
LGAC	-0.951
NVDA	-0.951

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

ImmunoPrecise Antibodies Korrelation - Währung/Rohstoff

0.74
( moderate )

0.72
( moderate )

0.00
( neutral )

0.76
( moderate )

-0.83
( strong negative )

-0.73
( moderate negative )

ImmunoPrecise Antibodies Finanzdaten

Annual	2022
Umsatz:	$20.67M
Bruttogewinn:	$11.56M (55.95 %)
EPS:	$-1.070

FY	2022
Umsatz:	$20.67M
Bruttogewinn:	$11.56M (55.95 %)
EPS:	$-1.070

FY	2022
Umsatz:	$19.36M
Bruttogewinn:	$10.98M (56.72 %)
EPS:	$-0.850

FY	2021
Umsatz:	$17.91M
Bruttogewinn:	$11.54M (64.41 %)
EPS:	$-0.450

Financial Reports:

No articles found.

ImmunoPrecise Antibodies

ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth factors, and hybridoma products for research purposes. Its contract research organization services include custom antigen modeling, design, and manufacturing; B cell sorting, screening, and sequencing; custom, immune, and naive phage display production and screening; transgenic animals and multi-species antibody discovery; bi-specific, tri-specific, VHH, and VNAR (shark) antibody manufacturing; DNA cloning, protein and antibody downstream processing; antibody characterization on label-free biosensors and antibody engineering; transient and stable cell line generation; antibody optimization and humanization; hybridoma production with multiplexed, high-throughput screening, and clone-picking; and cryopreservation. The company has research collaboration agreements with Pierre Fabre S.A for antibody discovery; and Elektrofi, Inc. to explore a high-concentration formulation of COVID-19 antibody cocktail, PolyTope TATX-03. ImmunoPrecise Antibodies Ltd. was incorporated in 1983 and is based in Victoria, Canada.